Oxinas Partners Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,494
Closed -$581K 117
2021
Q4
$581K Sell
9,494
-6,047
-39% -$370K 0.33% 73
2021
Q3
$1.16M Buy
15,541
+1,263
+9% +$94.4K 0.68% 47
2021
Q2
$1.32M Buy
14,278
+3,317
+30% +$307K 0.76% 39
2021
Q1
$973K Sell
10,961
-738
-6% -$65.5K 0.62% 53
2020
Q4
$1.09M Buy
+11,699
New +$1.09M 0.81% 36